Dual-Targeted Therapy Brings Remission to Half of Patients with Hardest-to-Treat Inflammatory Bowel Disease
A real-world study from Abu Dhabi found that pairing two advanced therapies with different mechanisms achieved combined clinical and biochemical ...
